Patienter, der opnåede HBV- DNA- niveauer < 3 log10 kopier/ ml inden uge 24, havde optimalt respons på behandlingen; omvendt havde patienter med HBV- DNA- niveauer > 4 log10 kopier/ ml ved uge 24 mindre favorable resultater ved uge 52.
Patients who achieve HBV DNA levels< 3 log10 copies/ml by week 24 had optimal responses to treatment; conversely patients with HBV DNA levels> 4 log10 copies/ ml at 24 weeks had less favourable outcomes at week 52.